Publication | Closed Access

Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study

First-line TherapyGastrointestinal OncologyMedicineModified Folfox-6PharmacologyColorectal CancerPathologyMetastatic Colorectal CancerCancer TreatmentOncologyRadiation Oncology